
Sign up to save your podcasts
Or


Over the past several years, the rise of GLP-1 drugs such as Ozempic and Wegovy has changed the conversation around weight and obesity in the U.S. Rachel Goldman, PhD, talks about how GLP-1s work; the effects they can have on mental health; what questions to ask if you’re considering trying these medications; how weight loss can shift people's relationships with their family, friends and partners; and why there’s still stigma around the use of GLP-1s and how patients can navigate that.
Find Dr. Rachel's new book at When Life Happens: The Mindset Shift You Need to Manage Stress, Build Confidence, and Break Free.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By American Psychological Association4.5
769769 ratings
Over the past several years, the rise of GLP-1 drugs such as Ozempic and Wegovy has changed the conversation around weight and obesity in the U.S. Rachel Goldman, PhD, talks about how GLP-1s work; the effects they can have on mental health; what questions to ask if you’re considering trying these medications; how weight loss can shift people's relationships with their family, friends and partners; and why there’s still stigma around the use of GLP-1s and how patients can navigate that.
Find Dr. Rachel's new book at When Life Happens: The Mindset Shift You Need to Manage Stress, Build Confidence, and Break Free.
Learn more about your ad choices. Visit megaphone.fm/adchoices

43,659 Listeners

816 Listeners

1,857 Listeners

675 Listeners

3,293 Listeners

1,413 Listeners

12,711 Listeners

1,344 Listeners

1,891 Listeners

291 Listeners

4,692 Listeners

14,355 Listeners

1,386 Listeners

731 Listeners

2,038 Listeners